SAGE THERAPEUTICS

Serial Number 86355377
Registration 4879416
701

Registration Progress

Application Filed
Aug 1, 2014
Under Examination
Approved for Publication
Jul 14, 2015
Published for Opposition
Jul 14, 2015
Registered
Jan 5, 2016

Attorney Assistance

Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-01-05)
Due: Jan 05, 2026 180 days

Basic Information

Serial Number
86355377
Registration Number
4879416
Filing Date
August 1, 2014
Registration Date
January 5, 2016
Published for Opposition
July 14, 2015
Drawing Code
3

Status Summary

Current Status
Active
Status Code
701
Status Date
Dec 23, 2022
Registration
Registered
Classes
042

Rights Holder

Sage Therapeutics, Inc.

03
Address
215 First Street
Cambridge, MA 02142

Ownership History

Sage Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Sage Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Sage Therapeutics, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Steven A. Abreu

USPTO Deadlines

Next Deadline
180 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-01-05)
Due Date
January 05, 2026
Grace Period Ends
July 05, 2026

Application History

34 events
Date Code Type Description
Jan 5, 2025 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 1, 2024 NA15 E SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Nov 1, 2024 15AK O REGISTERED - SEC. 15 ACKNOWLEDGED
Nov 1, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 22, 2024 E15R I TEAS SECTION 15 RECEIVED
Dec 23, 2022 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Dec 23, 2022 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED
Dec 23, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 1, 2022 ES8R I TEAS SECTION 8 RECEIVED
Jan 5, 2021 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 4, 2020 CCON T COUNTERCLAIM OPP. NO. 999999
Feb 10, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 27, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 27, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 5, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 27, 2015 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 13, 2015 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 14, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 14, 2015 PUBO A PUBLISHED FOR OPPOSITION
Jun 24, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 10, 2015 ALIE A ASSIGNED TO LIE
May 20, 2015 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 28, 2015 DOCK D ASSIGNED TO EXAMINER
Apr 8, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 22, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 22, 2014 GNRT F NON-FINAL ACTION E-MAILED
Nov 22, 2014 CNRT R NON-FINAL ACTION WRITTEN
Nov 15, 2014 DOCK D ASSIGNED TO EXAMINER
Aug 12, 2014 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 11, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2014 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Pharmaceutical research and development services, namely, research and development of pharmaceuticals to treat central nervous system disorders
First Use Anywhere: 20111000
First Use in Commerce: 20111000

Additional Information

Design Mark
The mark consists of the words "SAGE THERAPUTICS", to the left of which appears an image of a solid circle enclosed in a larger incomplete circle.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"